Jaguar Health earnings were -$52.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest JAGX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$12.7M, up 81.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, JAGX reported annual earnings of -$53.6M, with 39.2% growth. The next JAGX earnings date is Nov 13, 2026.
On JAGX's earnings call on Aug 19, 2026, Jaguar Health (NASDAQ: JAGX) reported Q2 2026 earnings per share (EPS) of -$236.00, up 95.62% year over year. Total JAGX earnings for the quarter were -$12.70 million. In the same quarter last year, Jaguar Health's earnings per share (EPS) was -$5,384.00.
The next JAGX earnings call is Nov 13, 2026. Add JAGX to your watchlist to be reminded of Jaguar Health's next earnings date.
What was JAGX's earnings growth in the past year?
As of Jaguar Health's earnings date in Aug 19, 2026, Jaguar Health's earnings has grown year over year. JAGX earnings in the past year totalled -$52.42 million.
Is Jaguar Health profitable or losing money?
As of the last Jaguar Health earnings report, Jaguar Health is currently losing money. Jaguar Health's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$36.40 million, a 10.45% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.